nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ALB—Levothyroxine—hypothyroidism	0.101	0.206	CbGbCtD
Imatinib—ALB—Liothyronine—hypothyroidism	0.101	0.206	CbGbCtD
Imatinib—ALB—Liotrix—hypothyroidism	0.0989	0.201	CbGbCtD
Imatinib—ABCB1—Levothyroxine—hypothyroidism	0.053	0.108	CbGbCtD
Imatinib—ABCB1—Liothyronine—hypothyroidism	0.053	0.108	CbGbCtD
Imatinib—ABCB1—Liotrix—hypothyroidism	0.0517	0.105	CbGbCtD
Imatinib—CYP3A4—Levothyroxine—hypothyroidism	0.0318	0.0647	CbGbCtD
Imatinib—KIT—seminiferous tubule of testis—hypothyroidism	0.0101	0.0482	CbGeAlD
Imatinib—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.005	0.0227	CcSEcCtD
Imatinib—Menstruation irregular—Levothyroxine—hypothyroidism	0.005	0.0227	CcSEcCtD
Imatinib—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00452	0.0205	CcSEcCtD
Imatinib—Menstruation irregular—Liotrix—hypothyroidism	0.00368	0.0167	CcSEcCtD
Imatinib—Angina pectoris—Liothyronine—hypothyroidism	0.00345	0.0157	CcSEcCtD
Imatinib—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00311	0.0141	CcSEcCtD
Imatinib—Myocardial infarction—Liothyronine—hypothyroidism	0.00309	0.0141	CcSEcCtD
Imatinib—ABCA3—heart—hypothyroidism	0.00299	0.0143	CbGeAlD
Imatinib—Intestinal obstruction—Liotrix—hypothyroidism	0.00299	0.0136	CcSEcCtD
Imatinib—DDR1—adrenal cortex—hypothyroidism	0.00286	0.0136	CbGeAlD
Imatinib—DDR1—heart—hypothyroidism	0.00276	0.0132	CbGeAlD
Imatinib—Necrosis—Liotrix—hypothyroidism	0.0026	0.0118	CcSEcCtD
Imatinib—HIPK4—gonad—hypothyroidism	0.00259	0.0124	CbGeAlD
Imatinib—Arrhythmia—Liothyronine—hypothyroidism	0.00253	0.0115	CcSEcCtD
Imatinib—CYP2C19—urine—hypothyroidism	0.00252	0.012	CbGeAlD
Imatinib—ABCA3—pituitary gland—hypothyroidism	0.0025	0.012	CbGeAlD
Imatinib—CA1—nerve—hypothyroidism	0.00246	0.0118	CbGeAlD
Imatinib—NTRK1—testis—hypothyroidism	0.00234	0.0112	CbGeAlD
Imatinib—DDR1—pituitary gland—hypothyroidism	0.00231	0.011	CbGeAlD
Imatinib—Cellulitis—Liotrix—hypothyroidism	0.00224	0.0102	CcSEcCtD
Imatinib—ABCA3—adrenal gland—hypothyroidism	0.00223	0.0107	CbGeAlD
Imatinib—ABCA3—blood—hypothyroidism	0.00223	0.0107	CbGeAlD
Imatinib—Hypocalcaemia—Liotrix—hypothyroidism	0.00223	0.0101	CcSEcCtD
Imatinib—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00222	0.0101	CcSEcCtD
Imatinib—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00222	0.0101	CcSEcCtD
Imatinib—ABCA3—thyroid gland—hypothyroidism	0.00216	0.0103	CbGeAlD
Imatinib—Ulcer—Liotrix—hypothyroidism	0.00215	0.0098	CcSEcCtD
Imatinib—Creatinine increased—Liotrix—hypothyroidism	0.00214	0.00973	CcSEcCtD
Imatinib—Increased appetite—Levothyroxine—hypothyroidism	0.00214	0.00973	CcSEcCtD
Imatinib—Increased appetite—Dextrothyroxine—hypothyroidism	0.00214	0.00973	CcSEcCtD
Imatinib—Hypertension—Liothyronine—hypothyroidism	0.00213	0.00968	CcSEcCtD
Imatinib—ABCA3—female gonad—hypothyroidism	0.00208	0.00995	CbGeAlD
Imatinib—DDR1—adrenal gland—hypothyroidism	0.00206	0.00985	CbGeAlD
Imatinib—DDR1—blood—hypothyroidism	0.00206	0.00985	CbGeAlD
Imatinib—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00206	0.00937	CcSEcCtD
Imatinib—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00206	0.00937	CcSEcCtD
Imatinib—Cardiac failure—Levothyroxine—hypothyroidism	0.00206	0.00937	CcSEcCtD
Imatinib—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00206	0.00937	CcSEcCtD
Imatinib—CYP1A2—urine—hypothyroidism	0.00206	0.00984	CbGeAlD
Imatinib—DDR1—thyroid gland—hypothyroidism	0.00199	0.00951	CbGeAlD
Imatinib—Tachycardia—Liothyronine—hypothyroidism	0.00196	0.00893	CcSEcCtD
Imatinib—CYP2C9—urine—hypothyroidism	0.00196	0.00934	CbGeAlD
Imatinib—Fluid retention—Liotrix—hypothyroidism	0.00194	0.0088	CcSEcCtD
Imatinib—DDR1—female gonad—hypothyroidism	0.00192	0.00919	CbGeAlD
Imatinib—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00191	0.00869	CcSEcCtD
Imatinib—Cardiac arrest—Levothyroxine—hypothyroidism	0.00191	0.00869	CcSEcCtD
Imatinib—Hypotension—Liothyronine—hypothyroidism	0.00188	0.00855	CcSEcCtD
Imatinib—Dehydration—Levothyroxine—hypothyroidism	0.00187	0.0085	CcSEcCtD
Imatinib—Dehydration—Dextrothyroxine—hypothyroidism	0.00187	0.0085	CcSEcCtD
Imatinib—HIPK4—testis—hypothyroidism	0.00187	0.00893	CbGeAlD
Imatinib—ABCA3—testis—hypothyroidism	0.00185	0.00883	CbGeAlD
Imatinib—Lightheadedness—Liotrix—hypothyroidism	0.00182	0.00829	CcSEcCtD
Imatinib—ABL2—heart—hypothyroidism	0.0018	0.00861	CbGeAlD
Imatinib—Muscular weakness—Levothyroxine—hypothyroidism	0.00177	0.00806	CcSEcCtD
Imatinib—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00177	0.00806	CcSEcCtD
Imatinib—Sepsis—Liotrix—hypothyroidism	0.00177	0.00804	CcSEcCtD
Imatinib—PIP4K2C—adrenal cortex—hypothyroidism	0.00176	0.00842	CbGeAlD
Imatinib—Dysphagia—Levothyroxine—hypothyroidism	0.00174	0.0079	CcSEcCtD
Imatinib—Dysphagia—Dextrothyroxine—hypothyroidism	0.00174	0.0079	CcSEcCtD
Imatinib—ABCA3—cerebellum—hypothyroidism	0.00171	0.00815	CbGeAlD
Imatinib—DDR1—testis—hypothyroidism	0.00171	0.00815	CbGeAlD
Imatinib—PIP4K2C—heart—hypothyroidism	0.00171	0.00815	CbGeAlD
Imatinib—Sweating increased—Levothyroxine—hypothyroidism	0.00169	0.0077	CcSEcCtD
Imatinib—Sweating increased—Dextrothyroxine—hypothyroidism	0.00169	0.0077	CcSEcCtD
Imatinib—Angina pectoris—Levothyroxine—hypothyroidism	0.00169	0.0077	CcSEcCtD
Imatinib—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00169	0.0077	CcSEcCtD
Imatinib—Cardiac failure congestive—Liotrix—hypothyroidism	0.00163	0.00742	CcSEcCtD
Imatinib—CA3—heart—hypothyroidism	0.00163	0.00778	CbGeAlD
Imatinib—DDR1—liver—hypothyroidism	0.00161	0.0077	CbGeAlD
Imatinib—Renal failure acute—Liotrix—hypothyroidism	0.0016	0.00728	CcSEcCtD
Imatinib—Body temperature increased—Liothyronine—hypothyroidism	0.00159	0.00723	CcSEcCtD
Imatinib—DDR1—cerebellum—hypothyroidism	0.00158	0.00753	CbGeAlD
Imatinib—Increased appetite—Liotrix—hypothyroidism	0.00157	0.00716	CcSEcCtD
Imatinib—Weight decreased—Levothyroxine—hypothyroidism	0.00157	0.00715	CcSEcCtD
Imatinib—Weight decreased—Dextrothyroxine—hypothyroidism	0.00157	0.00715	CcSEcCtD
Imatinib—CA3—cardiovascular system—hypothyroidism	0.00154	0.00734	CbGeAlD
Imatinib—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00153	0.00695	CcSEcCtD
Imatinib—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00153	0.00695	CcSEcCtD
Imatinib—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00152	0.00691	CcSEcCtD
Imatinib—Myocardial infarction—Levothyroxine—hypothyroidism	0.00152	0.00691	CcSEcCtD
Imatinib—Hypoglycaemia—Liotrix—hypothyroidism	0.00152	0.00689	CcSEcCtD
Imatinib—Cardiac failure—Liotrix—hypothyroidism	0.00152	0.00689	CcSEcCtD
Imatinib—LCK—heart—hypothyroidism	0.00151	0.00723	CbGeAlD
Imatinib—ABL2—pituitary gland—hypothyroidism	0.00151	0.0072	CbGeAlD
Imatinib—CYP3A4—urine—hypothyroidism	0.00149	0.00712	CbGeAlD
Imatinib—Sweating—Levothyroxine—hypothyroidism	0.00149	0.00675	CcSEcCtD
Imatinib—Sweating—Dextrothyroxine—hypothyroidism	0.00149	0.00675	CcSEcCtD
Imatinib—CA14—heart—hypothyroidism	0.00148	0.00706	CbGeAlD
Imatinib—CYP2D6—urine—hypothyroidism	0.00147	0.00701	CbGeAlD
Imatinib—PIP4K2C—gonad—hypothyroidism	0.00146	0.00698	CbGeAlD
Imatinib—PIP4K2C—pituitary gland—hypothyroidism	0.00142	0.00681	CbGeAlD
Imatinib—Cardiac arrest—Liotrix—hypothyroidism	0.00141	0.00639	CcSEcCtD
Imatinib—Blood creatinine increased—Liotrix—hypothyroidism	0.00139	0.0063	CcSEcCtD
Imatinib—Dehydration—Liotrix—hypothyroidism	0.00138	0.00625	CcSEcCtD
Imatinib—CA3—pituitary gland—hypothyroidism	0.00136	0.0065	CbGeAlD
Imatinib—Hypokalaemia—Liotrix—hypothyroidism	0.00135	0.00612	CcSEcCtD
Imatinib—ABL2—adrenal gland—hypothyroidism	0.00135	0.00643	CbGeAlD
Imatinib—ABL2—blood—hypothyroidism	0.00135	0.00643	CbGeAlD
Imatinib—Muscular weakness—Liotrix—hypothyroidism	0.0013	0.00593	CcSEcCtD
Imatinib—ABL2—thyroid gland—hypothyroidism	0.0013	0.0062	CbGeAlD
Imatinib—NQO2—adrenal cortex—hypothyroidism	0.0013	0.00619	CbGeAlD
Imatinib—Flushing—Levothyroxine—hypothyroidism	0.00129	0.00587	CcSEcCtD
Imatinib—Flushing—Dextrothyroxine—hypothyroidism	0.00129	0.00587	CcSEcCtD
Imatinib—Abdominal distension—Liotrix—hypothyroidism	0.00129	0.00585	CcSEcCtD
Imatinib—Dysphagia—Liotrix—hypothyroidism	0.00128	0.00581	CcSEcCtD
Imatinib—PIP4K2C—adrenal gland—hypothyroidism	0.00127	0.00608	CbGeAlD
Imatinib—PIP4K2C—blood—hypothyroidism	0.00127	0.00608	CbGeAlD
Imatinib—ABL2—female gonad—hypothyroidism	0.00125	0.00599	CbGeAlD
Imatinib—NQO2—heart—hypothyroidism	0.00125	0.00598	CbGeAlD
Imatinib—PDGFRA—heart—hypothyroidism	0.00125	0.00597	CbGeAlD
Imatinib—Angina pectoris—Liotrix—hypothyroidism	0.00125	0.00566	CcSEcCtD
Imatinib—Sweating increased—Liotrix—hypothyroidism	0.00125	0.00566	CcSEcCtD
Imatinib—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00124	0.00565	CcSEcCtD
Imatinib—Arrhythmia—Levothyroxine—hypothyroidism	0.00124	0.00565	CcSEcCtD
Imatinib—Alopecia—Levothyroxine—hypothyroidism	0.00123	0.00559	CcSEcCtD
Imatinib—Alopecia—Dextrothyroxine—hypothyroidism	0.00123	0.00559	CcSEcCtD
Imatinib—PIP4K2C—thyroid gland—hypothyroidism	0.00123	0.00587	CbGeAlD
Imatinib—PIP4K2C—female gonad—hypothyroidism	0.00119	0.00567	CbGeAlD
Imatinib—PDGFRA—cardiovascular system—hypothyroidism	0.00118	0.00563	CbGeAlD
Imatinib—CA3—thyroid gland—hypothyroidism	0.00117	0.0056	CbGeAlD
Imatinib—Weight decreased—Liotrix—hypothyroidism	0.00116	0.00526	CcSEcCtD
Imatinib—CSF1R—adrenal cortex—hypothyroidism	0.00114	0.00543	CbGeAlD
Imatinib—Tremor—Dextrothyroxine—hypothyroidism	0.00113	0.00516	CcSEcCtD
Imatinib—Tremor—Levothyroxine—hypothyroidism	0.00113	0.00516	CcSEcCtD
Imatinib—LCK—adrenal gland—hypothyroidism	0.00113	0.0054	CbGeAlD
Imatinib—LCK—blood—hypothyroidism	0.00113	0.0054	CbGeAlD
Imatinib—Acute coronary syndrome—Liotrix—hypothyroidism	0.00112	0.00511	CcSEcCtD
Imatinib—Renal failure—Liotrix—hypothyroidism	0.00112	0.00509	CcSEcCtD
Imatinib—Myocardial infarction—Liotrix—hypothyroidism	0.00112	0.00508	CcSEcCtD
Imatinib—ABL2—testis—hypothyroidism	0.00111	0.00532	CbGeAlD
Imatinib—Angioedema—Levothyroxine—hypothyroidism	0.00111	0.00503	CcSEcCtD
Imatinib—Angioedema—Dextrothyroxine—hypothyroidism	0.00111	0.00503	CcSEcCtD
Imatinib—CA14—adrenal gland—hypothyroidism	0.0011	0.00527	CbGeAlD
Imatinib—CSF1R—heart—hypothyroidism	0.0011	0.00526	CbGeAlD
Imatinib—Sweating—Liotrix—hypothyroidism	0.00109	0.00497	CcSEcCtD
Imatinib—LCK—thyroid gland—hypothyroidism	0.00109	0.00521	CbGeAlD
Imatinib—Palpitations—Levothyroxine—hypothyroidism	0.00107	0.00487	CcSEcCtD
Imatinib—Palpitations—Dextrothyroxine—hypothyroidism	0.00107	0.00487	CcSEcCtD
Imatinib—PDGFRA—gonad—hypothyroidism	0.00107	0.00511	CbGeAlD
Imatinib—LCK—female gonad—hypothyroidism	0.00105	0.00503	CbGeAlD
Imatinib—PIP4K2C—testis—hypothyroidism	0.00105	0.00503	CbGeAlD
Imatinib—ABL2—liver—hypothyroidism	0.00105	0.00503	CbGeAlD
Imatinib—Convulsion—Levothyroxine—hypothyroidism	0.00105	0.00477	CcSEcCtD
Imatinib—Convulsion—Dextrothyroxine—hypothyroidism	0.00105	0.00477	CcSEcCtD
Imatinib—NQO2—pituitary gland—hypothyroidism	0.00105	0.005	CbGeAlD
Imatinib—SLC47A1—adrenal cortex—hypothyroidism	0.00104	0.00496	CbGeAlD
Imatinib—CSF1R—cardiovascular system—hypothyroidism	0.00104	0.00496	CbGeAlD
Imatinib—Arthralgia—Dextrothyroxine—hypothyroidism	0.00103	0.00469	CcSEcCtD
Imatinib—Arthralgia—Levothyroxine—hypothyroidism	0.00103	0.00469	CcSEcCtD
Imatinib—Anxiety—Levothyroxine—hypothyroidism	0.00103	0.00467	CcSEcCtD
Imatinib—Anxiety—Dextrothyroxine—hypothyroidism	0.00103	0.00467	CcSEcCtD
Imatinib—ABL2—cerebellum—hypothyroidism	0.00103	0.00491	CbGeAlD
Imatinib—Hypoaesthesia—Liotrix—hypothyroidism	0.00102	0.00463	CcSEcCtD
Imatinib—CA7—cerebellum—hypothyroidism	0.00101	0.00483	CbGeAlD
Imatinib—PDGFRB—adrenal cortex—hypothyroidism	0.00101	0.00482	CbGeAlD
Imatinib—CA3—testis—hypothyroidism	0.00101	0.0048	CbGeAlD
Imatinib—SLC47A1—heart—hypothyroidism	0.001	0.0048	CbGeAlD
Imatinib—KIT—heart—hypothyroidism	0.000999	0.00477	CbGeAlD
Imatinib—Confusional state—Levothyroxine—hypothyroidism	0.000997	0.00453	CcSEcCtD
Imatinib—Confusional state—Dextrothyroxine—hypothyroidism	0.000997	0.00453	CcSEcCtD
Imatinib—PIP4K2C—liver—hypothyroidism	0.000995	0.00475	CbGeAlD
Imatinib—PDGFRB—heart—hypothyroidism	0.000976	0.00466	CbGeAlD
Imatinib—Shock—Levothyroxine—hypothyroidism	0.000973	0.00442	CcSEcCtD
Imatinib—Shock—Dextrothyroxine—hypothyroidism	0.000973	0.00442	CcSEcCtD
Imatinib—PIP4K2C—cerebellum—hypothyroidism	0.000972	0.00464	CbGeAlD
Imatinib—Tachycardia—Levothyroxine—hypothyroidism	0.000965	0.00439	CcSEcCtD
Imatinib—Tachycardia—Dextrothyroxine—hypothyroidism	0.000965	0.00439	CcSEcCtD
Imatinib—CA9—testis—hypothyroidism	0.000962	0.0046	CbGeAlD
Imatinib—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000956	0.00434	CcSEcCtD
Imatinib—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000956	0.00434	CcSEcCtD
Imatinib—CA3—liver—hypothyroidism	0.00095	0.00454	CbGeAlD
Imatinib—Flushing—Liotrix—hypothyroidism	0.00095	0.00432	CcSEcCtD
Imatinib—KIT—cardiovascular system—hypothyroidism	0.000943	0.0045	CbGeAlD
Imatinib—CSF1R—gonad—hypothyroidism	0.000942	0.0045	CbGeAlD
Imatinib—NQO2—adrenal gland—hypothyroidism	0.000935	0.00447	CbGeAlD
Imatinib—NQO2—blood—hypothyroidism	0.000935	0.00447	CbGeAlD
Imatinib—LCK—testis—hypothyroidism	0.000934	0.00446	CbGeAlD
Imatinib—PDGFRA—adrenal gland—hypothyroidism	0.000933	0.00446	CbGeAlD
Imatinib—PDGFRA—blood—hypothyroidism	0.000932	0.00445	CbGeAlD
Imatinib—PDGFRB—cardiovascular system—hypothyroidism	0.000921	0.0044	CbGeAlD
Imatinib—CSF1R—pituitary gland—hypothyroidism	0.000919	0.00439	CbGeAlD
Imatinib—Arrhythmia—Liotrix—hypothyroidism	0.000914	0.00416	CcSEcCtD
Imatinib—CA1—heart—hypothyroidism	0.000914	0.00436	CbGeAlD
Imatinib—Alopecia—Liotrix—hypothyroidism	0.000905	0.00411	CcSEcCtD
Imatinib—NQO2—thyroid gland—hypothyroidism	0.000902	0.00431	CbGeAlD
Imatinib—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000901	0.00409	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000901	0.00409	CcSEcCtD
Imatinib—PDGFRA—thyroid gland—hypothyroidism	0.0009	0.0043	CbGeAlD
Imatinib—ABL1—adrenal cortex—hypothyroidism	0.000899	0.0043	CbGeAlD
Imatinib—Insomnia—Dextrothyroxine—hypothyroidism	0.000894	0.00406	CcSEcCtD
Imatinib—Insomnia—Levothyroxine—hypothyroidism	0.000894	0.00406	CcSEcCtD
Imatinib—CA9—cerebellum—hypothyroidism	0.000889	0.00425	CbGeAlD
Imatinib—LCK—liver—hypothyroidism	0.000883	0.00422	CbGeAlD
Imatinib—Dyspnoea—Levothyroxine—hypothyroidism	0.000881	0.00401	CcSEcCtD
Imatinib—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000881	0.00401	CcSEcCtD
Imatinib—Flatulence—Liotrix—hypothyroidism	0.000878	0.00399	CcSEcCtD
Imatinib—Dysgeusia—Liotrix—hypothyroidism	0.000873	0.00397	CcSEcCtD
Imatinib—NQO2—female gonad—hypothyroidism	0.000872	0.00416	CbGeAlD
Imatinib—PDGFRA—female gonad—hypothyroidism	0.00087	0.00415	CbGeAlD
Imatinib—ABL1—heart—hypothyroidism	0.00087	0.00415	CbGeAlD
Imatinib—CA14—liver—hypothyroidism	0.000863	0.00412	CbGeAlD
Imatinib—CA1—cardiovascular system—hypothyroidism	0.000862	0.00412	CbGeAlD
Imatinib—SLC47A1—gonad—hypothyroidism	0.00086	0.00411	CbGeAlD
Imatinib—KIT—gonad—hypothyroidism	0.000855	0.00409	CbGeAlD
Imatinib—Fatigue—Dextrothyroxine—hypothyroidism	0.000852	0.00387	CcSEcCtD
Imatinib—Fatigue—Levothyroxine—hypothyroidism	0.000852	0.00387	CcSEcCtD
Imatinib—CYP3A7—liver—hypothyroidism	0.000844	0.00403	CbGeAlD
Imatinib—CA14—cerebellum—hypothyroidism	0.000843	0.00403	CbGeAlD
Imatinib—Vision blurred—Liotrix—hypothyroidism	0.00084	0.00382	CcSEcCtD
Imatinib—SLC47A1—pituitary gland—hypothyroidism	0.000839	0.00401	CbGeAlD
Imatinib—PDGFRB—gonad—hypothyroidism	0.000835	0.00399	CbGeAlD
Imatinib—Tremor—Liotrix—hypothyroidism	0.000835	0.00379	CcSEcCtD
Imatinib—KIT—pituitary gland—hypothyroidism	0.000835	0.00399	CbGeAlD
Imatinib—CSF1R—adrenal gland—hypothyroidism	0.000821	0.00392	CbGeAlD
Imatinib—CSF1R—blood—hypothyroidism	0.000821	0.00392	CbGeAlD
Imatinib—ABL1—cardiovascular system—hypothyroidism	0.00082	0.00392	CbGeAlD
Imatinib—PDGFRB—pituitary gland—hypothyroidism	0.000815	0.00389	CbGeAlD
Imatinib—Feeling abnormal—Levothyroxine—hypothyroidism	0.000815	0.0037	CcSEcCtD
Imatinib—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000815	0.0037	CcSEcCtD
Imatinib—Angioedema—Liotrix—hypothyroidism	0.000814	0.0037	CcSEcCtD
Imatinib—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000808	0.00367	CcSEcCtD
Imatinib—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000808	0.00367	CcSEcCtD
Imatinib—ALB—heart—hypothyroidism	0.000802	0.00383	CbGeAlD
Imatinib—Syncope—Liotrix—hypothyroidism	0.000799	0.00363	CcSEcCtD
Imatinib—CSF1R—thyroid gland—hypothyroidism	0.000792	0.00379	CbGeAlD
Imatinib—Palpitations—Liotrix—hypothyroidism	0.000787	0.00358	CcSEcCtD
Imatinib—Urticaria—Dextrothyroxine—hypothyroidism	0.000785	0.00357	CcSEcCtD
Imatinib—Urticaria—Levothyroxine—hypothyroidism	0.000785	0.00357	CcSEcCtD
Imatinib—Loss of consciousness—Liotrix—hypothyroidism	0.000783	0.00356	CcSEcCtD
Imatinib—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000782	0.00355	CcSEcCtD
Imatinib—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000782	0.00355	CcSEcCtD
Imatinib—Body temperature increased—Levothyroxine—hypothyroidism	0.000782	0.00355	CcSEcCtD
Imatinib—Abdominal pain—Levothyroxine—hypothyroidism	0.000782	0.00355	CcSEcCtD
Imatinib—NQO2—testis—hypothyroidism	0.000773	0.00369	CbGeAlD
Imatinib—Convulsion—Liotrix—hypothyroidism	0.000772	0.00351	CcSEcCtD
Imatinib—PDGFRA—testis—hypothyroidism	0.000771	0.00368	CbGeAlD
Imatinib—Hypertension—Liotrix—hypothyroidism	0.000769	0.0035	CcSEcCtD
Imatinib—CSF1R—female gonad—hypothyroidism	0.000766	0.00366	CbGeAlD
Imatinib—Arthralgia—Liotrix—hypothyroidism	0.000759	0.00345	CcSEcCtD
Imatinib—Chest pain—Liotrix—hypothyroidism	0.000759	0.00345	CcSEcCtD
Imatinib—Anxiety—Liotrix—hypothyroidism	0.000756	0.00344	CcSEcCtD
Imatinib—SLC47A1—adrenal gland—hypothyroidism	0.00075	0.00358	CbGeAlD
Imatinib—SLC47A1—blood—hypothyroidism	0.00075	0.00358	CbGeAlD
Imatinib—KIT—adrenal gland—hypothyroidism	0.000746	0.00356	CbGeAlD
Imatinib—KIT—blood—hypothyroidism	0.000745	0.00356	CbGeAlD
Imatinib—ABL1—gonad—hypothyroidism	0.000745	0.00356	CbGeAlD
Imatinib—Confusional state—Liotrix—hypothyroidism	0.000733	0.00333	CcSEcCtD
Imatinib—NQO2—liver—hypothyroidism	0.000731	0.00349	CbGeAlD
Imatinib—PDGFRA—liver—hypothyroidism	0.000729	0.00348	CbGeAlD
Imatinib—PDGFRB—adrenal gland—hypothyroidism	0.000728	0.00348	CbGeAlD
Imatinib—PDGFRB—blood—hypothyroidism	0.000728	0.00348	CbGeAlD
Imatinib—Anaphylactic shock—Liotrix—hypothyroidism	0.000727	0.00331	CcSEcCtD
Imatinib—Oedema—Liotrix—hypothyroidism	0.000727	0.00331	CcSEcCtD
Imatinib—ABL1—pituitary gland—hypothyroidism	0.000726	0.00347	CbGeAlD
Imatinib—SLC47A1—thyroid gland—hypothyroidism	0.000724	0.00346	CbGeAlD
Imatinib—Infection—Liotrix—hypothyroidism	0.000722	0.00328	CcSEcCtD
Imatinib—KIT—thyroid gland—hypothyroidism	0.000719	0.00344	CbGeAlD
Imatinib—CYP3A7-CYP3A51P—liver—hypothyroidism	0.000718	0.00343	CbGeAlD
Imatinib—Shock—Liotrix—hypothyroidism	0.000715	0.00325	CcSEcCtD
Imatinib—NQO2—cerebellum—hypothyroidism	0.000714	0.00341	CbGeAlD
Imatinib—PDGFRA—cerebellum—hypothyroidism	0.000712	0.0034	CbGeAlD
Imatinib—Tachycardia—Liotrix—hypothyroidism	0.00071	0.00323	CcSEcCtD
Imatinib—Asthenia—Levothyroxine—hypothyroidism	0.000709	0.00322	CcSEcCtD
Imatinib—Asthenia—Dextrothyroxine—hypothyroidism	0.000709	0.00322	CcSEcCtD
Imatinib—Hyperhidrosis—Liotrix—hypothyroidism	0.000703	0.0032	CcSEcCtD
Imatinib—PDGFRB—thyroid gland—hypothyroidism	0.000703	0.00336	CbGeAlD
Imatinib—Pruritus—Levothyroxine—hypothyroidism	0.000699	0.00318	CcSEcCtD
Imatinib—Pruritus—Dextrothyroxine—hypothyroidism	0.000699	0.00318	CcSEcCtD
Imatinib—SLC47A1—female gonad—hypothyroidism	0.000699	0.00334	CbGeAlD
Imatinib—KIT—female gonad—hypothyroidism	0.000695	0.00332	CbGeAlD
Imatinib—Anorexia—Liotrix—hypothyroidism	0.000693	0.00315	CcSEcCtD
Imatinib—ORM1—blood—hypothyroidism	0.000683	0.00326	CbGeAlD
Imatinib—CA1—blood—hypothyroidism	0.000682	0.00326	CbGeAlD
Imatinib—Hypotension—Liotrix—hypothyroidism	0.00068	0.00309	CcSEcCtD
Imatinib—CSF1R—testis—hypothyroidism	0.000679	0.00324	CbGeAlD
Imatinib—PDGFRB—female gonad—hypothyroidism	0.000679	0.00324	CbGeAlD
Imatinib—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000676	0.00307	CcSEcCtD
Imatinib—Diarrhoea—Levothyroxine—hypothyroidism	0.000676	0.00307	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000663	0.00301	CcSEcCtD
Imatinib—Insomnia—Liotrix—hypothyroidism	0.000658	0.00299	CcSEcCtD
Imatinib—Paraesthesia—Liotrix—hypothyroidism	0.000653	0.00297	CcSEcCtD
Imatinib—ABL1—adrenal gland—hypothyroidism	0.000649	0.0031	CbGeAlD
Imatinib—ABL1—blood—hypothyroidism	0.000649	0.0031	CbGeAlD
Imatinib—Dyspnoea—Liotrix—hypothyroidism	0.000648	0.00295	CcSEcCtD
Imatinib—CSF1R—liver—hypothyroidism	0.000642	0.00307	CbGeAlD
Imatinib—Decreased appetite—Liotrix—hypothyroidism	0.000632	0.00287	CcSEcCtD
Imatinib—Vomiting—Levothyroxine—hypothyroidism	0.000629	0.00286	CcSEcCtD
Imatinib—Vomiting—Dextrothyroxine—hypothyroidism	0.000629	0.00286	CcSEcCtD
Imatinib—CSF1R—cerebellum—hypothyroidism	0.000627	0.003	CbGeAlD
Imatinib—Fatigue—Liotrix—hypothyroidism	0.000627	0.00285	CcSEcCtD
Imatinib—ABL1—thyroid gland—hypothyroidism	0.000626	0.00299	CbGeAlD
Imatinib—SLC22A1—blood—hypothyroidism	0.000626	0.00299	CbGeAlD
Imatinib—Rash—Dextrothyroxine—hypothyroidism	0.000623	0.00283	CcSEcCtD
Imatinib—Rash—Levothyroxine—hypothyroidism	0.000623	0.00283	CcSEcCtD
Imatinib—Dermatitis—Dextrothyroxine—hypothyroidism	0.000623	0.00283	CcSEcCtD
Imatinib—Dermatitis—Levothyroxine—hypothyroidism	0.000623	0.00283	CcSEcCtD
Imatinib—Constipation—Liotrix—hypothyroidism	0.000622	0.00283	CcSEcCtD
Imatinib—SLC47A1—testis—hypothyroidism	0.00062	0.00296	CbGeAlD
Imatinib—Headache—Dextrothyroxine—hypothyroidism	0.000619	0.00282	CcSEcCtD
Imatinib—Headache—Levothyroxine—hypothyroidism	0.000619	0.00282	CcSEcCtD
Imatinib—KIT—testis—hypothyroidism	0.000617	0.00295	CbGeAlD
Imatinib—CA2—adrenal cortex—hypothyroidism	0.000612	0.00292	CbGeAlD
Imatinib—ABL1—female gonad—hypothyroidism	0.000605	0.00289	CbGeAlD
Imatinib—PDGFRB—testis—hypothyroidism	0.000602	0.00288	CbGeAlD
Imatinib—Feeling abnormal—Liotrix—hypothyroidism	0.000599	0.00272	CcSEcCtD
Imatinib—ALB—adrenal gland—hypothyroidism	0.000599	0.00286	CbGeAlD
Imatinib—Gastrointestinal pain—Liotrix—hypothyroidism	0.000595	0.0027	CcSEcCtD
Imatinib—CA2—heart—hypothyroidism	0.000592	0.00283	CbGeAlD
Imatinib—Nausea—Levothyroxine—hypothyroidism	0.000587	0.00267	CcSEcCtD
Imatinib—Nausea—Dextrothyroxine—hypothyroidism	0.000587	0.00267	CcSEcCtD
Imatinib—SLC47A1—liver—hypothyroidism	0.000586	0.0028	CbGeAlD
Imatinib—KIT—liver—hypothyroidism	0.000583	0.00278	CbGeAlD
Imatinib—Urticaria—Liotrix—hypothyroidism	0.000578	0.00263	CcSEcCtD
Imatinib—Abdominal pain—Liotrix—hypothyroidism	0.000575	0.00261	CcSEcCtD
Imatinib—Body temperature increased—Liotrix—hypothyroidism	0.000575	0.00261	CcSEcCtD
Imatinib—SLC47A1—cerebellum—hypothyroidism	0.000573	0.00274	CbGeAlD
Imatinib—KIT—cerebellum—hypothyroidism	0.000569	0.00272	CbGeAlD
Imatinib—PDGFRB—liver—hypothyroidism	0.000569	0.00272	CbGeAlD
Imatinib—ABCG2—adrenal cortex—hypothyroidism	0.000567	0.00271	CbGeAlD
Imatinib—CA2—cardiovascular system—hypothyroidism	0.000559	0.00267	CbGeAlD
Imatinib—PDGFRB—cerebellum—hypothyroidism	0.000556	0.00266	CbGeAlD
Imatinib—ABCG2—heart—hypothyroidism	0.000548	0.00262	CbGeAlD
Imatinib—ABL1—testis—hypothyroidism	0.000537	0.00256	CbGeAlD
Imatinib—Hypersensitivity—Liotrix—hypothyroidism	0.000536	0.00244	CcSEcCtD
Imatinib—ORM1—liver—hypothyroidism	0.000534	0.00255	CbGeAlD
Imatinib—CA1—liver—hypothyroidism	0.000533	0.00255	CbGeAlD
Imatinib—Asthenia—Liotrix—hypothyroidism	0.000522	0.00237	CcSEcCtD
Imatinib—Pruritus—Liotrix—hypothyroidism	0.000514	0.00234	CcSEcCtD
Imatinib—ABL1—liver—hypothyroidism	0.000507	0.00242	CbGeAlD
Imatinib—CYP2C9—heart—hypothyroidism	0.000501	0.00239	CbGeAlD
Imatinib—Diarrhoea—Liotrix—hypothyroidism	0.000498	0.00226	CcSEcCtD
Imatinib—ABL1—cerebellum—hypothyroidism	0.000496	0.00237	CbGeAlD
Imatinib—ALB—testis—hypothyroidism	0.000495	0.00237	CbGeAlD
Imatinib—CA2—pituitary gland—hypothyroidism	0.000495	0.00236	CbGeAlD
Imatinib—SLC22A1—liver—hypothyroidism	0.000489	0.00234	CbGeAlD
Imatinib—CYP2C19—blood—hypothyroidism	0.000482	0.0023	CbGeAlD
Imatinib—Dizziness—Liotrix—hypothyroidism	0.000481	0.00219	CcSEcCtD
Imatinib—CYP2C9—cardiovascular system—hypothyroidism	0.000473	0.00226	CbGeAlD
Imatinib—ALB—liver—hypothyroidism	0.000468	0.00224	CbGeAlD
Imatinib—Vomiting—Liotrix—hypothyroidism	0.000462	0.0021	CcSEcCtD
Imatinib—Rash—Liotrix—hypothyroidism	0.000459	0.00208	CcSEcCtD
Imatinib—ABCG2—pituitary gland—hypothyroidism	0.000458	0.00219	CbGeAlD
Imatinib—Dermatitis—Liotrix—hypothyroidism	0.000458	0.00208	CcSEcCtD
Imatinib—PTGS1—heart—hypothyroidism	0.000457	0.00218	CbGeAlD
Imatinib—Headache—Liotrix—hypothyroidism	0.000456	0.00207	CcSEcCtD
Imatinib—CA2—adrenal gland—hypothyroidism	0.000442	0.00211	CbGeAlD
Imatinib—CA2—blood—hypothyroidism	0.000442	0.00211	CbGeAlD
Imatinib—Nausea—Liotrix—hypothyroidism	0.000432	0.00196	CcSEcCtD
Imatinib—PTGS1—cardiovascular system—hypothyroidism	0.000432	0.00206	CbGeAlD
Imatinib—CA2—thyroid gland—hypothyroidism	0.000426	0.00204	CbGeAlD
Imatinib—CA2—female gonad—hypothyroidism	0.000412	0.00197	CbGeAlD
Imatinib—ABCG2—adrenal gland—hypothyroidism	0.000409	0.00196	CbGeAlD
Imatinib—ABCG2—blood—hypothyroidism	0.000409	0.00195	CbGeAlD
Imatinib—ABCG2—thyroid gland—hypothyroidism	0.000395	0.00189	CbGeAlD
Imatinib—CYP1A2—blood—hypothyroidism	0.000394	0.00188	CbGeAlD
Imatinib—PTGS1—pituitary gland—hypothyroidism	0.000382	0.00183	CbGeAlD
Imatinib—ABCG2—female gonad—hypothyroidism	0.000382	0.00182	CbGeAlD
Imatinib—CYP1A2—thyroid gland—hypothyroidism	0.00038	0.00182	CbGeAlD
Imatinib—CYP3A5—blood—hypothyroidism	0.00038	0.00181	CbGeAlD
Imatinib—CYP2C19—liver—hypothyroidism	0.000377	0.0018	CbGeAlD
Imatinib—CYP2C9—blood—hypothyroidism	0.000374	0.00179	CbGeAlD
Imatinib—CA2—testis—hypothyroidism	0.000365	0.00175	CbGeAlD
Imatinib—CYP3A5—female gonad—hypothyroidism	0.000354	0.00169	CbGeAlD
Imatinib—CA2—liver—hypothyroidism	0.000346	0.00165	CbGeAlD
Imatinib—PTGS1—adrenal gland—hypothyroidism	0.000341	0.00163	CbGeAlD
Imatinib—PTGS1—blood—hypothyroidism	0.000341	0.00163	CbGeAlD
Imatinib—ABCG2—testis—hypothyroidism	0.000338	0.00162	CbGeAlD
Imatinib—CA2—cerebellum—hypothyroidism	0.000338	0.00161	CbGeAlD
Imatinib—PTGS1—thyroid gland—hypothyroidism	0.000329	0.00157	CbGeAlD
Imatinib—ABCG2—liver—hypothyroidism	0.00032	0.00153	CbGeAlD
Imatinib—PTGS1—female gonad—hypothyroidism	0.000318	0.00152	CbGeAlD
Imatinib—ABCG2—cerebellum—hypothyroidism	0.000313	0.00149	CbGeAlD
Imatinib—CYP1A2—liver—hypothyroidism	0.000308	0.00147	CbGeAlD
Imatinib—CYP3A5—liver—hypothyroidism	0.000297	0.00142	CbGeAlD
Imatinib—CYP2C9—liver—hypothyroidism	0.000292	0.0014	CbGeAlD
Imatinib—CYP3A4—blood—hypothyroidism	0.000285	0.00136	CbGeAlD
Imatinib—PTGS1—testis—hypothyroidism	0.000282	0.00135	CbGeAlD
Imatinib—CYP2D6—blood—hypothyroidism	0.000281	0.00134	CbGeAlD
Imatinib—ABCB1—adrenal cortex—hypothyroidism	0.00028	0.00134	CbGeAlD
Imatinib—ABCB1—heart—hypothyroidism	0.00027	0.00129	CbGeAlD
Imatinib—CYP2D6—female gonad—hypothyroidism	0.000262	0.00125	CbGeAlD
Imatinib—ABCB1—cardiovascular system—hypothyroidism	0.000255	0.00122	CbGeAlD
Imatinib—CYP2D6—testis—hypothyroidism	0.000232	0.00111	CbGeAlD
Imatinib—ABCB1—gonad—hypothyroidism	0.000232	0.00111	CbGeAlD
Imatinib—ABCB1—pituitary gland—hypothyroidism	0.000226	0.00108	CbGeAlD
Imatinib—CYP3A4—liver—hypothyroidism	0.000223	0.00106	CbGeAlD
Imatinib—CYP2D6—liver—hypothyroidism	0.000219	0.00105	CbGeAlD
Imatinib—CYP2D6—cerebellum—hypothyroidism	0.000214	0.00102	CbGeAlD
Imatinib—ABCB1—adrenal gland—hypothyroidism	0.000202	0.000964	CbGeAlD
Imatinib—ABCB1—blood—hypothyroidism	0.000202	0.000964	CbGeAlD
Imatinib—ABCB1—thyroid gland—hypothyroidism	0.000195	0.00093	CbGeAlD
Imatinib—ABCB1—female gonad—hypothyroidism	0.000188	0.000899	CbGeAlD
Imatinib—ABCB1—testis—hypothyroidism	0.000167	0.000797	CbGeAlD
Imatinib—ABCB1—liver—hypothyroidism	0.000158	0.000754	CbGeAlD
Imatinib—ABCB1—cerebellum—hypothyroidism	0.000154	0.000736	CbGeAlD
Imatinib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	9.44e-05	0.00119	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—PRL—hypothyroidism	9.42e-05	0.00118	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—IYD—hypothyroidism	9.41e-05	0.00118	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—VAV3—hypothyroidism	9.41e-05	0.00118	CbGpPWpGaD
Imatinib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	9.36e-05	0.00118	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—IYD—hypothyroidism	9.33e-05	0.00117	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—IYD—hypothyroidism	9.32e-05	0.00117	CbGpPWpGaD
Imatinib—CA6—Metabolism—SLC5A5—hypothyroidism	9.26e-05	0.00116	CbGpPWpGaD
Imatinib—PDGFRB—Focal Adhesion—IGF1—hypothyroidism	9.12e-05	0.00115	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—IYD—hypothyroidism	9.04e-05	0.00114	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	8.85e-05	0.00111	CbGpPWpGaD
Imatinib—KIT—Immune System—CLTC—hypothyroidism	8.82e-05	0.00111	CbGpPWpGaD
Imatinib—ALB—Platelet degranulation—IGF1—hypothyroidism	8.74e-05	0.0011	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—IYD—hypothyroidism	8.68e-05	0.00109	CbGpPWpGaD
Imatinib—CA7—Metabolism—SLC5A5—hypothyroidism	8.64e-05	0.00109	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	8.6e-05	0.00108	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—VAV3—hypothyroidism	8.56e-05	0.00108	CbGpPWpGaD
Imatinib—SLC22A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	8.54e-05	0.00107	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CLTC—hypothyroidism	8.35e-05	0.00105	CbGpPWpGaD
Imatinib—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	8.32e-05	0.00105	CbGpPWpGaD
Imatinib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	8.32e-05	0.00105	CbGpPWpGaD
Imatinib—CA2—Metabolism—TSHB—hypothyroidism	8.18e-05	0.00103	CbGpPWpGaD
Imatinib—CA12—Metabolism—SLC5A5—hypothyroidism	8.01e-05	0.00101	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ATP5O—hypothyroidism	8e-05	0.00101	CbGpPWpGaD
Imatinib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	8e-05	0.001	CbGpPWpGaD
Imatinib—SLC22A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	7.96e-05	0.000999	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ATP5O—hypothyroidism	7.93e-05	0.000996	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ATP5O—hypothyroidism	7.92e-05	0.000995	CbGpPWpGaD
Imatinib—CYP3A7—Biological oxidations—POMC—hypothyroidism	7.91e-05	0.000993	CbGpPWpGaD
Imatinib—LCK—Hemostasis—SH2B3—hypothyroidism	7.91e-05	0.000993	CbGpPWpGaD
Imatinib—CA1—Metabolism—TSHB—hypothyroidism	7.84e-05	0.000985	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CLTC—hypothyroidism	7.78e-05	0.000978	CbGpPWpGaD
Imatinib—CA3—Metabolism—POMC—hypothyroidism	7.71e-05	0.000969	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ATP5O—hypothyroidism	7.69e-05	0.000966	CbGpPWpGaD
Imatinib—PTGS1—Biological oxidations—POMC—hypothyroidism	7.67e-05	0.000963	CbGpPWpGaD
Imatinib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.65e-05	0.000961	CbGpPWpGaD
Imatinib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.59e-05	0.000953	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.53e-05	0.000946	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—TPO—hypothyroidism	7.53e-05	0.000945	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CLTC—hypothyroidism	7.52e-05	0.000945	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—TPO—hypothyroidism	7.46e-05	0.000937	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—TPO—hypothyroidism	7.45e-05	0.000935	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ATP5O—hypothyroidism	7.38e-05	0.000927	CbGpPWpGaD
Imatinib—ABL1—Immune System—CLTC—hypothyroidism	7.33e-05	0.000921	CbGpPWpGaD
Imatinib—CA2—Metabolism—PIK3C2A—hypothyroidism	7.29e-05	0.000916	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—TPO—hypothyroidism	7.23e-05	0.000908	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—VAV3—hypothyroidism	7.14e-05	0.000897	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	7.12e-05	0.000895	CbGpPWpGaD
Imatinib—CA1—Metabolism—PIK3C2A—hypothyroidism	6.99e-05	0.000878	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—TPO—hypothyroidism	6.94e-05	0.000872	CbGpPWpGaD
Imatinib—CA9—Metabolism—TSHB—hypothyroidism	6.89e-05	0.000866	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	6.76e-05	0.000849	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—VAV3—hypothyroidism	6.76e-05	0.000849	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—IYD—hypothyroidism	6.74e-05	0.000847	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TRH—hypothyroidism	6.73e-05	0.000845	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—VAV3—hypothyroidism	6.72e-05	0.000844	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.7e-05	0.000841	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—VAV3—hypothyroidism	6.59e-05	0.000828	CbGpPWpGaD
Imatinib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.48e-05	0.000814	CbGpPWpGaD
Imatinib—LCK—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	6.48e-05	0.000814	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	6.29e-05	0.00079	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.24e-05	0.000784	CbGpPWpGaD
Imatinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.17e-05	0.000775	CbGpPWpGaD
Imatinib—CA9—Metabolism—PIK3C2A—hypothyroidism	6.14e-05	0.000772	CbGpPWpGaD
Imatinib—CA2—Metabolism—SLC5A5—hypothyroidism	6.12e-05	0.000769	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—VAV3—hypothyroidism	6.09e-05	0.000765	CbGpPWpGaD
Imatinib—LCK—Immune System—CLTC—hypothyroidism	6.04e-05	0.000758	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TSHB—hypothyroidism	6e-05	0.000753	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TSHR—hypothyroidism	6e-05	0.000753	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—VAV3—hypothyroidism	5.93e-05	0.000745	CbGpPWpGaD
Imatinib—CA1—Metabolism—SLC5A5—hypothyroidism	5.87e-05	0.000737	CbGpPWpGaD
Imatinib—ALB—Metabolism—IYD—hypothyroidism	5.81e-05	0.00073	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ATP5O—hypothyroidism	5.73e-05	0.00072	CbGpPWpGaD
Imatinib—CYP3A5—Biological oxidations—POMC—hypothyroidism	5.72e-05	0.000718	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CLTC—hypothyroidism	5.7e-05	0.000716	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.57e-05	0.000699	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.51e-05	0.000692	CbGpPWpGaD
Imatinib—LCK—Hemostasis—VAV3—hypothyroidism	5.43e-05	0.000682	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CLTC—hypothyroidism	5.4e-05	0.000678	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—TPO—hypothyroidism	5.39e-05	0.000677	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—SH2B3—hypothyroidism	5.35e-05	0.000671	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	5.32e-05	0.000669	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—IYD—hypothyroidism	5.21e-05	0.000655	CbGpPWpGaD
Imatinib—CA9—Metabolism—SLC5A5—hypothyroidism	5.16e-05	0.000648	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.14e-05	0.000645	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—IYD—hypothyroidism	5.09e-05	0.000639	CbGpPWpGaD
Imatinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5e-05	0.000628	CbGpPWpGaD
Imatinib—CA14—Metabolism—POMC—hypothyroidism	4.97e-05	0.000624	CbGpPWpGaD
Imatinib—ALB—Metabolism—ATP5O—hypothyroidism	4.94e-05	0.00062	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TRH—hypothyroidism	4.93e-05	0.000619	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—VAV3—hypothyroidism	4.89e-05	0.000614	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CLTC—hypothyroidism	4.86e-05	0.000611	CbGpPWpGaD
Imatinib—CA6—Metabolism—POMC—hypothyroidism	4.84e-05	0.000608	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—IYD—hypothyroidism	4.8e-05	0.000602	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—IYD—hypothyroidism	4.75e-05	0.000597	CbGpPWpGaD
Imatinib—ALB—Hemostasis—SH2B3—hypothyroidism	4.73e-05	0.000594	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TRH—hypothyroidism	4.67e-05	0.000586	CbGpPWpGaD
Imatinib—ALB—Metabolism—TPO—hypothyroidism	4.64e-05	0.000583	CbGpPWpGaD
Imatinib—CA7—Metabolism—POMC—hypothyroidism	4.52e-05	0.000568	CbGpPWpGaD
Imatinib—KIT—Immune System—PRL—hypothyroidism	4.49e-05	0.000564	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ATP5O—hypothyroidism	4.43e-05	0.000557	CbGpPWpGaD
Imatinib—CYP2C19—Biological oxidations—POMC—hypothyroidism	4.42e-05	0.000555	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TSHB—hypothyroidism	4.39e-05	0.000552	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TSHR—hypothyroidism	4.39e-05	0.000552	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.38e-05	0.000551	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.34e-05	0.000545	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ATP5O—hypothyroidism	4.33e-05	0.000544	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.3e-05	0.00054	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—PRL—hypothyroidism	4.25e-05	0.000534	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TRH—hypothyroidism	4.2e-05	0.000528	CbGpPWpGaD
Imatinib—CA12—Metabolism—POMC—hypothyroidism	4.19e-05	0.000526	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—TPO—hypothyroidism	4.17e-05	0.000524	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TSHB—hypothyroidism	4.16e-05	0.000522	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TSHR—hypothyroidism	4.16e-05	0.000522	CbGpPWpGaD
Imatinib—KIT—Immune System—VAV3—hypothyroidism	4.16e-05	0.000522	CbGpPWpGaD
Imatinib—KIT—Disease—PRL—hypothyroidism	4.15e-05	0.000521	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ATP5O—hypothyroidism	4.08e-05	0.000512	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—TPO—hypothyroidism	4.07e-05	0.000511	CbGpPWpGaD
Imatinib—CYP2D6—Biological oxidations—POMC—hypothyroidism	4.07e-05	0.000511	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—IYD—hypothyroidism	4.06e-05	0.00051	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—IGF1—hypothyroidism	4.06e-05	0.00051	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—AVP—hypothyroidism	4.04e-05	0.000508	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ATP5O—hypothyroidism	4.04e-05	0.000508	CbGpPWpGaD
Imatinib—CYP2C9—Biological oxidations—POMC—hypothyroidism	4.03e-05	0.000506	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—PRL—hypothyroidism	3.97e-05	0.000498	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—VAV3—hypothyroidism	3.94e-05	0.000494	CbGpPWpGaD
Imatinib—PDGFRA—Disease—PRL—hypothyroidism	3.93e-05	0.000493	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—SH2B3—hypothyroidism	3.92e-05	0.000492	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CLTC—hypothyroidism	3.9e-05	0.00049	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	3.88e-05	0.000487	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.86e-05	0.000485	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—TPO—hypothyroidism	3.83e-05	0.000482	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—PRL—hypothyroidism	3.83e-05	0.000481	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	3.82e-05	0.000479	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—TPO—hypothyroidism	3.8e-05	0.000477	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TSHB—hypothyroidism	3.75e-05	0.000471	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TSHR—hypothyroidism	3.75e-05	0.000471	CbGpPWpGaD
Imatinib—ABL1—Immune System—PRL—hypothyroidism	3.73e-05	0.000469	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—SH2B3—hypothyroidism	3.71e-05	0.000466	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—VAV3—hypothyroidism	3.67e-05	0.000461	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—VAV3—hypothyroidism	3.55e-05	0.000445	CbGpPWpGaD
Imatinib—PDGFRB—Disease—PRL—hypothyroidism	3.54e-05	0.000444	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—AVP—hypothyroidism	3.53e-05	0.000444	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.52e-05	0.000442	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—TSHB—hypothyroidism	3.48e-05	0.000438	CbGpPWpGaD
Imatinib—ABL1—Immune System—VAV3—hypothyroidism	3.46e-05	0.000434	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ATP5O—hypothyroidism	3.45e-05	0.000434	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—TSHB—hypothyroidism	3.45e-05	0.000434	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—TSHB—hypothyroidism	3.45e-05	0.000433	CbGpPWpGaD
Imatinib—CYP1A2—Biological oxidations—POMC—hypothyroidism	3.44e-05	0.000433	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.44e-05	0.000432	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TRH—hypothyroidism	3.37e-05	0.000424	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—TSHB—hypothyroidism	3.35e-05	0.00042	CbGpPWpGaD
Imatinib—LCK—Hemostasis—IGF1—hypothyroidism	3.34e-05	0.00042	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—SH2B3—hypothyroidism	3.34e-05	0.000419	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—TPO—hypothyroidism	3.25e-05	0.000408	CbGpPWpGaD
Imatinib—ALB—Hemostasis—VAV3—hypothyroidism	3.24e-05	0.000407	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—TSHB—hypothyroidism	3.21e-05	0.000404	CbGpPWpGaD
Imatinib—CA2—Metabolism—POMC—hypothyroidism	3.2e-05	0.000402	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—IYD—hypothyroidism	3.14e-05	0.000394	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PIK3C2A—hypothyroidism	3.11e-05	0.00039	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	3.08e-05	0.000387	CbGpPWpGaD
Imatinib—LCK—Immune System—PRL—hypothyroidism	3.08e-05	0.000386	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PIK3C2A—hypothyroidism	3.07e-05	0.000386	CbGpPWpGaD
Imatinib—CA1—Metabolism—POMC—hypothyroidism	3.07e-05	0.000386	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.01e-05	0.000378	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.01e-05	0.000378	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TSHB—hypothyroidism	3.01e-05	0.000378	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TSHR—hypothyroidism	3.01e-05	0.000378	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PIK3C2A—hypothyroidism	2.98e-05	0.000375	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.94e-05	0.00037	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PRL—hypothyroidism	2.91e-05	0.000365	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PIK3C2A—hypothyroidism	2.86e-05	0.00036	CbGpPWpGaD
Imatinib—LCK—Immune System—VAV3—hypothyroidism	2.85e-05	0.000357	CbGpPWpGaD
Imatinib—LCK—Disease—PRL—hypothyroidism	2.84e-05	0.000357	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PRL—hypothyroidism	2.75e-05	0.000345	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	2.71e-05	0.00034	CbGpPWpGaD
Imatinib—CA9—Metabolism—POMC—hypothyroidism	2.7e-05	0.000339	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—VAV3—hypothyroidism	2.69e-05	0.000338	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SH2B3—hypothyroidism	2.68e-05	0.000337	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.67e-05	0.000335	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.66e-05	0.000334	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—SLC5A5—hypothyroidism	2.61e-05	0.000328	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—AVP—hypothyroidism	2.59e-05	0.000325	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—SLC5A5—hypothyroidism	2.59e-05	0.000325	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—SLC5A5—hypothyroidism	2.58e-05	0.000324	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—VAV3—hypothyroidism	2.54e-05	0.00032	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TPO—hypothyroidism	2.51e-05	0.000315	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—SLC5A5—hypothyroidism	2.51e-05	0.000315	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—TSHB—hypothyroidism	2.5e-05	0.000314	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PRL—hypothyroidism	2.48e-05	0.000311	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—AVP—hypothyroidism	2.45e-05	0.000308	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—SLC5A5—hypothyroidism	2.41e-05	0.000302	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.37e-05	0.000298	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—POMC—hypothyroidism	2.35e-05	0.000295	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—VAV3—hypothyroidism	2.29e-05	0.000288	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IGF1—hypothyroidism	2.26e-05	0.000284	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	2.22e-05	0.000279	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—AVP—hypothyroidism	2.21e-05	0.000277	CbGpPWpGaD
Imatinib—ALB—Metabolism—TSHB—hypothyroidism	2.15e-05	0.00027	CbGpPWpGaD
Imatinib—ALB—Hemostasis—IGF1—hypothyroidism	2e-05	0.000251	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PRL—hypothyroidism	1.99e-05	0.00025	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—TSHB—hypothyroidism	1.93e-05	0.000242	CbGpPWpGaD
Imatinib—ALB—Metabolism—PIK3C2A—hypothyroidism	1.92e-05	0.000241	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.89e-05	0.000237	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—TSHB—hypothyroidism	1.88e-05	0.000237	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—SLC5A5—hypothyroidism	1.87e-05	0.000235	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—VAV3—hypothyroidism	1.84e-05	0.000231	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—TSHB—hypothyroidism	1.78e-05	0.000223	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—AVP—hypothyroidism	1.77e-05	0.000223	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—TSHB—hypothyroidism	1.76e-05	0.000221	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—POMC—hypothyroidism	1.72e-05	0.000216	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	1.72e-05	0.000216	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.7e-05	0.000213	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.68e-05	0.000211	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IGF1—hypothyroidism	1.66e-05	0.000208	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—POMC—hypothyroidism	1.63e-05	0.000205	CbGpPWpGaD
Imatinib—ALB—Metabolism—SLC5A5—hypothyroidism	1.61e-05	0.000202	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	1.58e-05	0.000199	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	1.57e-05	0.000197	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IGF1—hypothyroidism	1.57e-05	0.000197	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.55e-05	0.000194	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—TSHB—hypothyroidism	1.5e-05	0.000189	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—POMC—hypothyroidism	1.47e-05	0.000184	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SLC5A5—hypothyroidism	1.44e-05	0.000181	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IGF1—hypothyroidism	1.41e-05	0.000177	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SLC5A5—hypothyroidism	1.41e-05	0.000177	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—POMC—hypothyroidism	1.36e-05	0.000171	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—POMC—hypothyroidism	1.35e-05	0.00017	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—POMC—hypothyroidism	1.35e-05	0.00017	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	1.34e-05	0.000168	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SLC5A5—hypothyroidism	1.33e-05	0.000167	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.32e-05	0.000166	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SLC5A5—hypothyroidism	1.32e-05	0.000165	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—POMC—hypothyroidism	1.31e-05	0.000165	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—POMC—hypothyroidism	1.26e-05	0.000158	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—POMC—hypothyroidism	1.18e-05	0.000148	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TSHB—hypothyroidism	1.16e-05	0.000146	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IGF1—hypothyroidism	1.13e-05	0.000142	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SLC5A5—hypothyroidism	1.13e-05	0.000141	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.03e-05	0.00013	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—POMC—hypothyroidism	9.78e-06	0.000123	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SLC5A5—hypothyroidism	8.69e-06	0.000109	CbGpPWpGaD
Imatinib—ALB—Metabolism—POMC—hypothyroidism	8.42e-06	0.000106	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—POMC—hypothyroidism	7.56e-06	9.49e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—POMC—hypothyroidism	7.38e-06	9.27e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—POMC—hypothyroidism	6.95e-06	8.73e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—POMC—hypothyroidism	6.89e-06	8.66e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—POMC—hypothyroidism	5.89e-06	7.4e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—POMC—hypothyroidism	4.55e-06	5.71e-05	CbGpPWpGaD
